153 related articles for article (PubMed ID: 2070077)
1. Purification and properties of heparin-releasable lipoprotein-associated coagulation inhibitor.
Novotny WF; Palmier M; Wun TC; Broze GJ; Miletich JP
Blood; 1991 Jul; 78(2):394-400. PubMed ID: 2070077
[TBL] [Abstract][Full Text] [Related]
2. Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma.
Novotny WF; Girard TJ; Miletich JP; Broze GJ
J Biol Chem; 1989 Nov; 264(31):18832-7. PubMed ID: 2553722
[TBL] [Abstract][Full Text] [Related]
3. Immunoaffinity purification and characterization of lipoprotein-associated coagulation inhibitors from Hep G2 hepatoma, Chang liver, and SK hepatoma cells. A comparative study.
Wun TC; Huang MD; Kretzmer KK; Palmier MO; Day KC; Bulock JW; Fok KF; Broze GJ
J Biol Chem; 1990 Sep; 265(27):16096-101. PubMed ID: 2168880
[TBL] [Abstract][Full Text] [Related]
4. Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples.
Novotny WF; Brown SG; Miletich JP; Rader DJ; Broze GJ
Blood; 1991 Jul; 78(2):387-93. PubMed ID: 2070076
[TBL] [Abstract][Full Text] [Related]
5. The lipoprotein-associated coagulation inhibitor.
Broze GJ; Girard TJ; Novotny WF
Prog Hemost Thromb; 1991; 10():243-68. PubMed ID: 2008533
[TBL] [Abstract][Full Text] [Related]
6. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action.
Broze GJ; Warren LA; Novotny WF; Higuchi DA; Girard JJ; Miletich JP
Blood; 1988 Feb; 71(2):335-43. PubMed ID: 3422166
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein-associated coagulation inhibitor (LACI) is a cofactor for heparin: synergistic anticoagulant action between LACI and sulfated polysaccharides.
Wun TC
Blood; 1992 Jan; 79(2):430-8. PubMed ID: 1346095
[TBL] [Abstract][Full Text] [Related]
8. Identification of the 1.4 kb and 4.0 kb messages for the lipoprotein associated coagulation inhibitor and expression of the encoded protein.
Girard TJ; Warren LA; Novotny WF; Bejcek BE; Miletich JP; Broze GJ
Thromb Res; 1989 Jul; 55(1):37-50. PubMed ID: 2781520
[TBL] [Abstract][Full Text] [Related]
9. Tissue factor pathway inhibitor with high anticoagulant activity is increased in post-heparin plasma and in plasma from cancer patients.
Lindahl AK; Jacobsen PB; Sandset PM; Abildgaard U
Blood Coagul Fibrinolysis; 1991 Dec; 2(6):713-21. PubMed ID: 1799658
[TBL] [Abstract][Full Text] [Related]
10. Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa.
Wesselschmidt R; Likert K; Girard T; Wun TC; Broze GJ
Blood; 1992 Apr; 79(8):2004-10. PubMed ID: 1562726
[TBL] [Abstract][Full Text] [Related]
11. Effect of lipoprotein-associated coagulation inhibitor (LACI) on thromboplastin-induced coagulation of normal and hemophiliac plasmas.
Welsch DJ; Novotny WF; Wun TC
Thromb Res; 1991 Oct; 64(2):213-22. PubMed ID: 1811340
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions.
Pedersen AH; Nordfang O; Norris F; Wiberg FC; Christensen PM; Moeller KB; Meidahl-Pedersen J; Beck TC; Norris K; Hedner U
J Biol Chem; 1990 Oct; 265(28):16786-93. PubMed ID: 2211593
[TBL] [Abstract][Full Text] [Related]
13. Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis.
Bajaj MS; Kuppuswamy MN; Saito H; Spitzer SG; Bajaj SP
Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8869-73. PubMed ID: 2247459
[TBL] [Abstract][Full Text] [Related]
14. Endogenous phosphorylation of the lipoprotein-associated coagulation inhibitor at serine-2.
Girard TJ; McCourt D; Novotny WF; MacPhail LA; Likert KM; Broze GJ
Biochem J; 1990 Sep; 270(3):621-5. PubMed ID: 2122883
[TBL] [Abstract][Full Text] [Related]
15. Structure of the human lipoprotein-associated coagulation inhibitor gene. Intro/exon gene organization and localization of the gene to chromosome 2.
Girard TJ; Eddy R; Wesselschmidt RL; MacPhail LA; Likert KM; Byers MG; Shows TB; Broze GJ
J Biol Chem; 1991 Mar; 266(8):5036-41. PubMed ID: 2002045
[TBL] [Abstract][Full Text] [Related]
16. Binding of lipoprotein lipase to apolipoprotein B-containing lipoproteins.
Carrero P; Gómez-Coronado D; Olivecrona G; Lasunción MA
Biochim Biophys Acta; 1996 Jan; 1299(2):198-206. PubMed ID: 8555265
[TBL] [Abstract][Full Text] [Related]
17. Intron-exon organization of the human gene coding for the lipoprotein-associated coagulation inhibitor: the factor Xa dependent inhibitor of the extrinsic pathway of coagulation.
van der Logt CP; Reitsma PH; Bertina RM
Biochemistry; 1991 Feb; 30(6):1571-7. PubMed ID: 1993173
[TBL] [Abstract][Full Text] [Related]
18. The use of heparin-sepharose affinity chromatography to separate two distinct lipoproteins from the low density lipoprotein fraction of rat plasma.
Suri BS; Targ ME; Robinson DS
Atherosclerosis; 1984 Nov; 53(2):195-205. PubMed ID: 6440566
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of factor VIIa-tissue factor coagulation activity by a hybrid protein.
Girard TJ; MacPhail LA; Likert KM; Novotny WF; Miletich JP; Broze GJ
Science; 1990 Jun; 248(4961):1421-4. PubMed ID: 1972598
[TBL] [Abstract][Full Text] [Related]
20. Utilization of a continuous flow reactor to study the lipoprotein-associated coagulation inhibitor (LACI) that inhibits tissue factor.
Gemmell CH; Broze GJ; Turitto VT; Nemerson Y
Blood; 1990 Dec; 76(11):2266-71. PubMed ID: 2257300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
